Related Experiment Video
Updated: Mar 21, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Xanthogranulomatous cystitis associated with inflammatory bowel disease
Doreen E Chung1, Lesley K Carr, Linda Sugar
1Clinical Assistant Professor, Section of Urology, The University of Chicago, Chicago, IL;
Xanthogranulomatous cystitis (XGC) is a rare benign bladder condition. This report details the 23rd case, the third linked to inflammatory bowel disease (IBD), highlighting successful transurethral resection.
Area of Science:
- Uropathology
- Gastroenterology
Background:
- Xanthogranulomatous inflammation is a benign condition involving giant cells, inflammatory cells, and lipid-laden macrophages (xanthoma cells).
- Xanthogranulomatous cystitis (XGC) is exceptionally rare, with only 22 prior reported cases in global literature.
- Association between XGC and inflammatory bowel disease (IBD) is exceedingly uncommon.
Purpose of the Study:
- To report the 23rd case of xanthogranulomatous cystitis (XGC).
- To document the third case of XGC associated with inflammatory bowel disease (IBD).
- To describe the clinical presentation, management, and outcome of a patient with XGC and Crohn's disease.
Main Methods:
- Case presentation of a 50-year-old woman with quiescent Crohn's disease.
- Incidental detection of a bladder mass via ultrasound.
- Surgical resection of the lesion using a transurethral approach.
- Histopathological examination of the resected tissue to confirm XGC.
Main Results:
- Pathology confirmed the diagnosis of xanthogranulomatous cystitis (XGC).
- The patient had a history of quiescent Crohn's disease, making this a rare association.
- No recurrence of the bladder mass was observed at 3 months post-transurethral resection.
Conclusions:
- Xanthogranulomatous cystitis (XGC) is a rare differential diagnosis for bladder masses, even in patients with inflammatory bowel disease (IBD).
- Transurethral resection is an effective treatment modality for XGC.
- Continued surveillance is important, although this case showed no early recurrence.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

